Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SMARCA4: Current status and future perspectives in non-small-cell lung cancer
Yumeng Tian, Lu Xu, Xin Li, et al.
Cancer Letters (2022) Vol. 554, pp. 216022-216022
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

New promises and challenges in the treatment of advanced non-small-cell lung cancer
May-Lucie Meyer, Bailey G Fitzgerald, Luis Paz‐Ares, et al.
The Lancet (2024) Vol. 404, Iss. 10454, pp. 803-822
Closed Access | Times Cited: 44
Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor
Ying Lin, Bo Yu, Haifeng Sun, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 11, pp. 8663-8671
Open Access | Times Cited: 18
Role Of Epigenetic Drugs In Sensitizing Cancers To Anticancer Therapies: Emerging Trends And Clinical Advancements
Deepti Singh, Mohammad Afsar Khan, Hifzur R. Siddique
Epigenomics (2023) Vol. 15, Iss. 8, pp. 517-537
Closed Access | Times Cited: 17
Lung Cancer Research and Treatment: Global Perspectives and Strategic Calls to Action
May-Lucie Meyer, S. Peters, Tony Mok, et al.
Annals of Oncology (2024)
Closed Access | Times Cited: 7
Application of PROTACs in target identification and validation
Yang Liu, Jing Liang, Rui Zhu, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 6
Melittin kills A549 cells by targeting mitochondria and blocking mitophagy flux
Xuan Li, Zheng Li, Yuqi Meng, et al.
Redox Report (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 13
LncRNAs and the Cancer Epigenome: Mechanisms and Therapeutic Potential
Revathy Nadhan, Ciro Isidoro, Yong Sang Song, et al.
Cancer Letters (2024) Vol. 605, pp. 217297-217297
Closed Access | Times Cited: 5
SMARCA4-deficient non-small cell lung carcinoma: clinicodemographic, computed tomography, and positron emission tomography-computed tomography features
Jong Hee Kim, Jung Han Woo, Chae Young Lim, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 3, pp. 1753-1764
Open Access | Times Cited: 4
Re-analysis of single cell and spatial transcriptomics data reveals B cell landscape in gastric cancer microenvironment and its potential crosstalk with tumor cells for clinical prognosis
Xing Cai, Jinru Yang, Yusheng Guo, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Refining prognostic assessment of diffuse large B-cell lymphoma: insights from multi-omics and single-cell analysis unveil SRM as a key target for regulating immunotherapy
Xiaojie Liang, Jia Guo, Baiwei Luo, et al.
Journal Of Big Data (2025) Vol. 12, Iss. 1
Open Access
CNPY2 expression as a diagnostic and prognostic biomarker in non-small cell lung cancer
Jiang Xiao, Jun Chen, Shujun Ding, et al.
Clinical Biochemistry (2025), pp. 110895-110895
Closed Access
Proteomic analysis reveals chromatin remodeling as a potential therapeutical target in neuroblastoma
Zan Liu, Zitong Zhao, Longlong Xie, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Transcriptional regulation by LKB1 in lung adenocarcinomas: exploring oxidative stress, neuroglial and amino acid signatures
Marie Mével‐Aliset, A Radu, Jordan Allard, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 755, pp. 151571-151571
Closed Access
Brain metastases lung adenocarcinoma patients with BRG1 loss have a grim prognosis, featuring unique morphological and methylation characteristics
Junjie Yang, Feng Jing, Zejun Duan, et al.
Clinical & Experimental Metastasis (2025) Vol. 42, Iss. 3
Open Access
Anti-SARS-CoV-2 and anticancer properties of triptolide and its derived carbonized nanomaterials
Rubina Kousar, Tahira Akhtar, Chin‐Jung Lin, et al.
Cancer Letters (2025), pp. 217677-217677
Open Access
SMARCA4-deficient non-small cell lung cancer with metastasis to the sigmoid colon: a case report
R. Xiao, Guang Fu, Xinglan Li, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Pan-cancer analysis reveals BAF complexes as immune-related biomarkers and validation in triple-negative breast cancer
Shuying Dai, Bei Li, Qingqian Wu, et al.
Life Sciences (2025), pp. 123607-123607
Closed Access
HDAC4 Super-Enhancer Drives CEBPB-Mediated TWIST2 Transcription to Promote Chemoresistance in LUAD
Min Jiang, Kai Zhang, Guohao Wei, et al.
Cancer Letters (2025), pp. 217716-217716
Closed Access
Engineered lung cell targeting and SLC7A11 siRNA expressing bacterial extracellular vesicles impair the progression of none‐small cell lung cancer
Xiaodan Wan, Xueliang Zhou, Jinlong Liu, et al.
Bioengineering & Translational Medicine (2025)
Open Access
SMARCA4-deficient undifferentiated carcinoma: A rare tumor with significant clinical challenges
Xiang Yu, L. Yao
Asian Journal of Surgery (2025)
Open Access
Novel Metal Complex-Based Nanomaterials with Excellent Fluorescence Performance and its Treatment on Lung Cancer Cells
Xiao Liu, Shilan Liu, Qinghui Yang, et al.
Journal of Inorganic and Organometallic Polymers and Materials (2024)
Closed Access | Times Cited: 3
Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on Cancer Therapies including Immunotherapy
Yijiang Shi, Daniel Sanghoon Shin
Biomolecules (2023) Vol. 13, Iss. 6, pp. 984-984
Open Access | Times Cited: 7
NUT carcinoma and thoracic SMARCA4‐deficient undifferentiated tumour: facts and controversies
Akihiko Yoshida
Histopathology (2023) Vol. 84, Iss. 1, pp. 86-101
Open Access | Times Cited: 7
Enhancer‐activated RET confers protection against oxidative stress to KMT2A‐rearranged acute myeloid leukemia
Brendan Frett, Kimberly E. Stephens, Brian Koss, et al.
Cancer Science (2024) Vol. 115, Iss. 3, pp. 963-973
Open Access | Times Cited: 2
SMARCA4-deficient non-small cell lung cancer: a case description and literature analysis
Ruiyan Ye, Anqi Wu, Lin Chen, et al.
Quantitative Imaging in Medicine and Surgery (2024) Vol. 14, Iss. 6, pp. 4215-4222
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top